The promising investigational targeted therapy ibrutinib and its mechanism of silencing gene communication pathways critical to the development of cancer may be an effective way to combat chronic… read more.
An experimental drug combination for preventing graft-versus-host disease (GVHD) was not significantly better than the standard regimen on key endpoints, according to a report of a phase 3… read more.
by Gary Finnegan – EMA Highlights – The EMA has given the green light to a new vaccine for bacterial meningitis. Bexsero, by Novartis, provides broad coverage against… read more.
by Bruce Sylvester – FDA Highlights – According to a study published online on September 7, 2012 in the American Journal of Respiratory and Critical Care Medicine, treatment… read more.
by Bruce Sylvester – FDA Highlights – A study published online on August 27, 2012 in The Lancet suggests that gabapentin, a pain and seizure drug, significantly reduces… read more.
by Gary Finnegan – World Health Matters (Japan) – Researchers in Japan have called for mandatory visual field testing for drivers in light of evidence showing glaucoma may… read more.
by Bruce Sylvester – Researchers at Boston Children’s Hospital and the Massachusetts Institute of Technology report the discovery a potential method to delay the onset of neuropathic pain.
by Bruce Sylvester – Researchers at Boston Children’s Hospital and the Massachusetts Institute of Technology report the discovery a potential method to delay the onset of neuropathic pain.
by Marybeth Burke – Some of the most essential mainstays in cancer treatment drugs for adults and children are in short supply, Michael Link, M.D., president of the… read more.
It is estimated that as many as 24 million European men aged 50 and over experience bothersome urinary symptoms.1,2 Yet, despite experiencing symptoms, men typically wait nearly two… read more.
Spanish scientists have confirmed that there is a clear relationship between androgenetic alopecia (common premature baldness) and benign prostate hyperplasia (BPH),
Second study sheds light on the ‘obesity paradox’ People can be obese but metabolically healthy and fit, with no greater risk of developing or dying from cardiovascular disease… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
